logo
15:59 Dec 05

Balaxi Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
34.10
-0.87 (-2.49%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Balaxi Pharmaceuticals Ltd. Financials

Balaxi Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
34.10
-0.87 (-2.49%)
15:59 Dec 05
Quality
image/svg+xml

54/100
Medium Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

24/100
Technically Bearish

Strength

3

Weakness

15

Opportunity

0

Threats

0

10.81 %

ROE %

8.07 %

ROA %

2.63

EPS

41.98

BVPS

8.56 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
279.39 336.43 241.29 292.56 297.68
Operating Expenses +
229.19 279.9 194.56 255.36 266.39
Raw Material
195.6 202.42 128.68 165.7 127.57
Increase Decrease in Cost
0 0 0 0 0
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
12.47 28.95 28.04 34.74 35.04
Miscellaneous Expenses
21.12 48.53 37.84 54.92 103.78
Operating Profit
50.2 56.53 46.73 37.2 31.29
Other Income
4.97 2.64 -2.65 -3.72 -3.64
Depreciation
0.51 1.75 2.1 1.89 1.86
Interest
0.14 0.5 1.68 2.93 3.58
Profit before tax and exceptio..
54.52 56.92 40.31 28.67 22.21
Exceptional Items
0 0 -38.29 0 0
PBT
54.52 56.92 2.02 28.67 22.21
Provision for Taxation
6.86 10.96 4.4 3.6 3.32
Net Profit
47.66 45.96 -2.39 25.07 18.88
NET Profit after MI
47.66 45.96 -2.39 25.07 18.88
EPS
47.66 45.4 -2.32 4.54 3.42
Operating Profit Margin (%)
17.97 16.8 19.37 12.72 10.51
Net Profit Margin (%)
17.06 13.66 -0.99 8.57 6.34

Balaxi Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 66.00 66.00 66.00 66.00 66.00 66.00
FII 3.50 8.90 16.00 16.50 16.50 16.90
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 30.50 25.10 18.00 17.50 17.50 17.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: